A data-driven financial justification for an outpatient infectious diseases pharmacist

Area of Science:

• Infectious Diseases
• Health Economics
• Pharmacy Practice

Background:

• Staphylococcus aureus infections pose a significant clinical and economic burden.
• Optimizing antimicrobial therapy is crucial for patient outcomes and resource management.
• The role of specialized pharmacists in managing complex infections is increasingly recognized.

Purpose of the Study:

• To provide a financial justification for establishing an outpatient infectious diseases pharmacist position.
• To quantify cost savings associated with reduced length of stay for Staphylococcus aureus infections.
• To assess the revenue-generating potential of pharmacist-led outpatient parenteral antimicrobial therapy (OPAT) management.

Main Methods:

• Retrospective analysis of patient data for Staphylococcus aureus infections.
• Cost-effectiveness modeling comparing standard care with pharmacist intervention.
• Evaluation of physician and pharmacist time allocation and billing for OPAT services.

Main Results:

• Implementation of an outpatient infectious diseases pharmacist led to significant cost savings through decreased length of stay.
• The specialized pharmacist role generated additional revenue for physicians and pharmacists.
• Improved patient monitoring during outpatient parenteral antimicrobial therapy contributed to financial benefits.

Conclusions:

• An outpatient infectious diseases pharmacist is a financially viable and beneficial addition to healthcare systems.
• This role enhances patient care while simultaneously reducing healthcare costs and increasing revenue.
• Investing in specialized infectious diseases pharmacy services is recommended for optimizing resource allocation and patient management.